Khiron Life Sciences Corp.
KHRNH.V
TSX
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -2.74M | -1.70M | -4.27M | -15.47M | -2.65M |
| Total Depreciation and Amortization | 426.10K | 511.60K | 470.60K | 120.20K | 270.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.30K | -1.16M | 1.31M | 11.10M | -649.40K |
| Change in Net Operating Assets | -1.55M | 785.00K | 277.10K | 153.10K | -824.10K |
| Cash from Operations | -3.87M | -1.57M | -2.21M | -4.10M | -3.85M |
| Capital Expenditure | -574.10K | -298.50K | -250.30K | -918.90K | -147.70K |
| Sale of Property, Plant, and Equipment | -- | -6.30K | 6.30K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -271.40K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -94.30K | -66.60K | -- | 22.40K | -22.20K |
| Cash from Investing | -668.30K | -371.30K | -244.00K | -1.17M | -169.90K |
| Total Debt Issued | 694.00K | 1.00K | 109.00K | -169.50K | 169.00K |
| Total Debt Repaid | 169.00K | -254.00K | -303.00K | 641.00K | 84.00K |
| Issuance of Common Stock | 0.00 | 4.61M | -- | -- | 12.35M |
| Repurchase of Common Stock | -- | -- | -- | -5.46M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.00K | -744.00K | -- | 5.46M | -1.52M |
| Cash from Financing | 662.20K | 2.83M | -153.20K | 373.80K | 8.79M |
| Foreign Exchange rate Adjustments | 898.30K | -348.60K | -386.90K | -265.50K | -97.70K |
| Miscellaneous Cash Flow Adjustments | -800.00 | 800.00 | -- | 800.00 | 143.70K |
| Net Change in Cash | -2.97M | 541.30K | -3.00M | -5.16M | 4.82M |
